ReShape Lifesciences Inc. has announced that its shareholders have approved all necessary proposals for the merger with Vyome Therapeutics. The merger is expected to become effective on August 15, 2025, aligning with the commencement of trading of the combined company's shares under the new name Vyome Holdings, Inc. on The Nasdaq Capital Market, with the trading symbol "HIND". The merger emphasizes Vyome's aim to establish a healthcare platform across the US-India innovation corridor. Both companies are supported by financial advisors and legal counsel, indicating a coordinated effort to ensure a smooth transition.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ReShape Lifesciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250807164498) on August 07, 2025, and is solely responsible for the information contained therein.